GO:0032967 positive regulation of collagen biosynthetic process: Biosynthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032967 describes any process that activates or increases the frequency, rate or extent of collagen biosynthesis, the production of the fibrous structural proteins that form the main component of connective tissue.
• Collagen gene expression is controlled at transcriptional and post-transcriptional levels, and its dysregulation underlies fibrosis, cancer stroma remodeling and connective tissue disease.
• Positive regulation of collagen biosynthesis is driven by growth factors and cytokines such as TGF-beta, and by metabolic signals including lactate-dependent H3K18 lactylation that stimulates the LTBP3/TGF-beta1 axis.
• Secretory pathway proteostasis factors, including P4HB/PDIA1 and the ER stress sensor IRE1, modulate collagen folding and secretion and are tractable anti-fibrotic targets.
• Pharmacological blockade of collagen and collagen-like cargo secretion, for example with dextromethorphan, can ameliorate lung fibrosis in experimental models.
• CRISPR knockout, point-mutation, knock-in and overexpression cell models allow causal testing of candidate regulators of collagen biosynthesis in fibrosis, cancer and skin biology.
Description
GO:0032967, positive regulation of collagen biosynthetic process, is a Gene Ontology biological process term that covers any process which activates or increases the frequency, rate or extent of the chemical reactions and pathways leading to the formation of collagen. Collagen is a family of fibrous proteins of very high tensile strength that constitute the main structural component of connective tissue in animals, and its production must be tightly controlled to preserve tissue architecture. Because collagen synthesis is a multi-step process spanning transcription, mRNA stability, translation, post-translational modification, folding and secretion, positive regulation can be exerted at any of these levels. For researchers, GO:0032967 is a useful annotation axis because it groups mechanistically diverse activators of collagen production under a single functional label. Classical work established that collagen gene expression is regulated by both transcriptional and post-transcriptional mechanisms, and that extracellular signals such as growth factors and cytokines strongly influence the rate of collagen synthesis. More recent studies have extended this framework to include metabolic and proteostasis-dependent control, showing that lactate-driven epigenetic changes and ER-resident folding factors can promote collagen expression and secretion. Understanding positive regulation of collagen biosynthesis matters because excessive or mislocalized collagen deposition is a hallmark of fibrotic disease and of the desmoplastic stroma of many tumors. Conversely, insufficient collagen production contributes to connective tissue fragility. This article summarizes the definition, mechanism, key genes, disease links and experimental methods relevant to GO:0032967, with all factual statements supported by the cited literature.
positive regulation of collagen biosynthetic process At A Glance
| GO ID | GO:0032967 |
|---|---|
| GO term | positive regulation of collagen biosynthetic process |
| Ontology | biological_process |
| Synonym | positive regulation of collagen anabolism; positive regulation of collagen biosynthesis; positive regulation of collagen formation; positive regulation of collagen synthesis |
| Major function | Increases the frequency, rate or extent of collagen formation, the main structural protein of connective tissue |
| Definition source | QuickGO definition of GO:0032967 |
| Biological context | Connective tissue homeostasis, wound healing, fibrosis, tumor stroma remodeling |
| Representative regulators | TGF-beta signaling, LTBP3, lactate/H3K18 lactylation, ER proteostasis factors such as P4HB/PDIA1 and IRE1 |
| Disease relevance | Lung fibrosis, liver fibrosis, keloid formation, gastric cancer and colorectal cancer stroma |
What Is GO:0032967?
In plain terms, GO:0032967 is the GO label for any biological activity that turns up the production of collagen. Formally, it is defined as any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. It is a biological_process term whose synonyms include positive regulation of collagen anabolism, positive regulation of collagen biosynthesis, positive regulation of collagen formation and positive regulation of collagen synthesis. The term is a positive regulatory node: it does not describe collagen synthesis itself, but the upstream or intrinsic signals that increase it, such as growth factor signaling, metabolic reprogramming or changes in secretory pathway capacity.
Why Is positive regulation of collagen biosynthetic process Important in Cell Biology?
Positive regulation of collagen biosynthesis is important because collagen is the principal tensile element of connective tissue, and the rate at which it is produced determines tissue strength, wound repair and the balance between normal and pathological matrix accumulation. When this process is chronically activated, it drives fibrosis in organs such as lung and liver, and it contributes to the dense collagen-rich stroma that supports tumor growth and progression. Because the process is regulated at multiple levels, from transcription to secretion, it offers many potential intervention points for experimental and therapeutic research.
• Collagen is the main component of connective tissue and provides tensile strength to skin, bone, tendon and internal organs.
• Positive regulation of collagen biosynthesis is required for normal wound healing and tissue repair.
• Chronic activation of collagen production causes organ fibrosis, including lung and liver fibrosis.
• Collagen-rich tumor stroma is associated with tumor enlargement and progression in gastric cancer.
• Metabolic signals such as lactate can promote collagen expression in keloid fibroblasts through H3K18 lactylation and the LTBP3/TGF-beta1 axis.
• ER proteostasis factors, including P4HB/PDIA1 and IRE1, control collagen folding and secretion and are anti-fibrotic targets.
• Inhibiting collagen and collagen-like cargo secretion can ameliorate experimental lung fibrosis.
• Collagen gene expression is regulated transcriptionally and post-transcriptionally, providing multiple experimental entry points.
• Skin keratinocytes and fibroblasts respond to exogenous stimuli such as polydeoxyribonucleotide with opposing ERK activity, illustrating cell-type-specific control of matrix production.
• Tumor-stroma interactions can regulate polarity and matrix programs in mucinous colorectal adenocarcinoma.
What Happens During positive regulation of collagen biosynthetic process?
Transcriptional activation of collagen genes
In simple terms: The cell first receives a signal telling it to make more collagen, and this switches on the collagen genes.
Positive regulation of collagen biosynthesis begins with signals that increase transcription of collagen genes. Classical studies established that collagen gene expression is controlled at the transcriptional level and that extracellular cues such as growth factors and cytokines modulate the rate of collagen mRNA synthesis. In keloid fibroblasts, lactate promotes collagen expression through H3K18 lactylation-dependent stimulation of the LTBP3/TGF-beta1 axis, linking metabolic state to transcriptional activation of the collagen program. This step determines the available pool of collagen mRNA and is a major control point for the entire process.
Post-transcriptional and translational control
In simple terms: After the gene is switched on, the cell can still adjust how much collagen protein is actually made from the mRNA.
Collagen biosynthesis is also regulated after transcription. Molecular mechanisms of collagen gene expression include changes in mRNA stability and translational efficiency, which allow the cell to fine-tune collagen output without altering transcription. This layer of control means that positive regulation of collagen biosynthesis can be achieved by stabilizing collagen transcripts or enhancing their translation, and it explains why collagen production can change rapidly in response to extracellular signals.
Post-translational modification and folding in the ER
In simple terms: The newly made collagen protein must be chemically modified and folded correctly inside the cell before it can be used.
Nascent collagen polypeptides undergo post-translational modifications and folding in the endoplasmic reticulum, a step that is sensitive to the proteostasis environment. The ER stress sensor IRE1 protects the liver from fibrosis through downregulation of the proteostasis factor P4HB/PDIA1, indicating that ER folding machinery directly influences collagen biosynthesis and secretion. Positive regulation of collagen biosynthesis therefore includes processes that increase the capacity or efficiency of these folding and modification steps.
Secretory pathway trafficking and export
In simple terms: Once folded, collagen must be packaged and shipped out of the cell to reach the extracellular matrix.
Collagen and collagen-like cargo must transit the secretory pathway to be deposited in the extracellular matrix. Dextromethorphan inhibits collagen and collagen-like cargo secretion and ameliorates lung fibrosis, demonstrating that the secretion step is a regulated and druggable component of collagen biosynthesis. Positive regulation of collagen biosynthetic process thus encompasses signals that enhance secretory trafficking of collagen, in addition to signals that increase its synthesis.
Integration with tissue-level matrix remodeling
In simple terms: The whole tissue responds by laying down more collagen matrix, which changes how stiff and supportive the tissue becomes.
At the tissue level, increased collagen biosynthesis contributes to matrix remodeling in fibrosis and in the tumor microenvironment. Collagen family genes are involved in tumor enlargement of gastric cancer, and signaling downstream of tumor-stroma interaction regulates polarity programs in mucinous colorectal adenocarcinoma, illustrating how collagen production is integrated with tissue architecture. Positive regulation of collagen biosynthesis therefore represents a node where cell-intrinsic signals converge with tissue-level demands for matrix deposition.
Key Genes Involved in GO:0032967 positive regulation of collagen biosynthetic process
The following genes and proteins are representative participants or regulators of positive regulation of collagen biosynthetic process, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| COL1A1 | Encodes the alpha-1 chain of type I collagen, a major fibrillar collagen | Core structural gene whose expression defines collagen biosynthetic output |
| COL1A2 | Encodes the alpha-2 chain of type I collagen | Partner chain for type I collagen heterotrimer assembly |
| COL3A1 | Encodes type III collagen, abundant in soft connective tissue | Marker of early fibrosis and matrix remodeling |
| COL5A1 | Encodes type V collagen, a regulator of fibril assembly | Modulates collagen fibril diameter and matrix organization |
| COL6A1 | Encodes a chain of type VI collagen microfibrils | Connects cells to the surrounding matrix and is implicated in tumor stroma |
| LTBP3 | Latent TGF-beta binding protein 3, regulates TGF-beta availability | Lactate-dependent H3K18 lactylation stimulates the LTBP3/TGF-beta1 axis to promote collagen expression |
| TGFB1 | Transforming growth factor beta 1, a master pro-fibrotic cytokine | Central activator of collagen gene transcription in fibrosis and keloid |
| P4HB/PDIA1 | Protein disulfide isomerase and ER proteostasis factor | Downregulated by IRE1 targeting; controls collagen folding and liver fibrosis |
| ERN1 (IRE1) | ER stress sensor and kinase/endonuclease | Targeting IRE1 protects the liver from fibrosis via P4HB/PDIA1 downregulation |
| ERK1/ERK2 (MAPK3/MAPK1) | Mitogen-activated protein kinases | ERK activity in keratinocytes and fibroblasts is modulated by polydeoxyribonucleotide, influencing matrix production |
| COL4A1 | Encodes a chain of basement membrane type IV collagen | Basement membrane collagen relevant to tissue architecture |
| COL11A1 | Encodes a minor fibrillar collagen chain | Associated with collagen family gene involvement in tumor enlargement |
| COL10A1 | Encodes type X collagen, a marker of hypertrophic cartilage | Collagen family member studied in tumor contexts |
| COL17A1 | Encodes a transmembrane collagen in skin | Skin biology and keratinocyte-fibroblast crosstalk |
| MMP1 | Matrix metalloproteinase 1, degrades interstitial collagen | Counterbalances collagen deposition and matrix turnover |
| LOX | Lysyl oxidase, crosslinks collagen fibrils | Determines matrix stiffness downstream of collagen synthesis |
| SP1 | Transcription factor regulating collagen promoters | Transcriptional control of collagen gene expression |
| NFI (nuclear factor I) | Transcription factor family regulating collagen genes | Molecular mechanisms of collagen gene expression |
How Is positive regulation of collagen biosynthetic process Regulated?
Positive regulation of collagen biosynthetic process is controlled by a layered regulatory network. Growth factor and cytokine signaling, notably through TGF-beta1 and its latent binding partner LTBP3, activates collagen gene transcription, and this axis can be stimulated by metabolic signals such as lactate via H3K18 lactylation in keloid fibroblasts. Transcriptional regulators and post-transcriptional mechanisms further tune collagen mRNA levels and translation, as established by classical studies of collagen gene expression. In parallel, the secretory pathway and ER proteostasis machinery set a ceiling on how much collagen can be folded and exported; the ER stress sensor IRE1 influences this capacity by regulating P4HB/PDIA1, and pharmacological inhibition of collagen secretion can reduce fibrosis. Finally, kinase signaling such as ERK activity in skin cells can modulate matrix production in a cell-type-specific manner.
positive regulation of collagen biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LTBP3 / TGFB1 | Keloid and fibrotic skin scarring | Keloid fibroblast knockout or overexpression of LTBP3 with lactate stimulation |
| P4HB/PDIA1 / ERN1 | Liver fibrosis and ER proteostasis | Hepatocyte or hepatic stellate cell knockout of ERN1 or P4HB |
| COL1A1 | Lung fibrosis and excessive collagen deposition | Lung fibroblast COL1A1 knockout and secretion assays |
| COL family genes | Gastric cancer tumor enlargement | Gastric cancer cell lines with collagen gene knockout or knockdown |
| Stroma signaling genes | Mucinous colorectal adenocarcinoma polarity | Colorectal cancer organoid co-cultures with stromal cells |
Lung fibrosis
Excessive positive regulation of collagen biosynthesis contributes to lung fibrosis, where increased collagen deposition stiffens the lung parenchyma. Dextromethorphan inhibits collagen and collagen-like cargo secretion and ameliorates lung fibrosis, showing that blocking the secretory arm of collagen biosynthesis can be therapeutic in this setting. This makes lung fibrosis a key disease context for studying GO:0032967.
Liver fibrosis
In the liver, ER proteostasis and stress signaling control collagen production. Targeting the ER stress sensor IRE1 protects the liver from fibrosis through downregulation of the proteostasis factor P4HB/PDIA1, linking positive regulation of collagen biosynthesis to hepatic fibrogenesis. This pathway provides candidate targets for anti-fibrotic intervention.
Keloid and skin matrix disorders
Keloid fibroblasts show enhanced collagen expression driven by lactate-dependent H3K18 lactylation and stimulation of the LTBP3/TGF-beta1 axis, directly implicating positive regulation of collagen biosynthesis in abnormal skin scarring. Skin keratinocytes and fibroblasts also respond to exogenous polydeoxyribonucleotide with opposing ERK activity, indicating cell-type-specific control of matrix production in skin.
Cancer stroma and tumor progression
Collagen family genes are involved in tumor enlargement of gastric cancer, and tumor-stroma interaction signaling regulates polarity programs in mucinous colorectal adenocarcinoma, indicating that collagen biosynthesis in the tumor microenvironment supports cancer progression. Positive regulation of collagen biosynthesis is therefore relevant to desmoplastic stroma biology and to stroma-targeted therapeutic strategies.
From positive regulation of collagen biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for collagen biosynthesis? | CRISPR knockout cell model with collagen readout |
| Does a specific amino acid substitution alter collagen regulation? | Point-mutation knock-in cell model |
| Does a regulatory element or tag affect collagen gene output? | Knock-in of reporter or epitope tag at the collagen locus |
| Does increased gene dosage drive collagen production? | Overexpression cell model |
| Which ER proteostasis factors control collagen secretion? | Knockout of ERN1 or P4HB with secretion assays |
| Can secretion inhibitors reduce collagen deposition? | Fibroblast model treated with dextromethorphan |
How to Study the positive regulation of collagen biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RT-qPCR | Collagen mRNA levels | Validation of transcriptional activation |
| RNA-seq | Global transcriptome changes | Pathway-level analysis of collagen regulation |
| Western blot | Collagen protein abundance | Confirmation of protein-level changes |
| Pulse-chase secretion assay | Folding and export of newly synthesized collagen | Testing secretion inhibitors and proteostasis factors |
| Immunofluorescence | Collagen deposition and localization | Fibrosis and matrix remodeling studies |
| Sirius red / second harmonic imaging | Fibrillar collagen content and organization | Tissue-level fibrosis and tumor stroma analysis |
| CRISPR knockout screen | Genes required for collagen biosynthesis | Unbiased discovery of regulators |
| Bioinformatic pathway enrichment | Functional annotation of candidate genes | Prioritizing hits for GO:0032967 validation |
Transcript and protein quantification
Quantitative PCR, RNA-seq and western blotting are used to measure collagen mRNA and protein levels after genetic or pharmacological perturbation, providing a direct readout of positive regulation of collagen biosynthesis. These methods are foundational for validating candidate regulators identified in screens.
Secretory pathway and proteostasis assays
Pulse-chase labeling, secretion assays and ER stress reporters can quantify how much newly synthesized collagen is folded and exported, which is essential because positive regulation can act at the secretion step. Such assays are used to test inhibitors of collagen and collagen-like cargo secretion.
Imaging and matrix deposition analysis
Immunofluorescence, second harmonic generation imaging and Sirius red staining visualize collagen deposition and matrix organization in cells and tissues, linking molecular regulation to tissue-level outcomes. These approaches are useful in fibrosis and tumor stroma studies.
CRISPR screening and bioinformatics
Pooled CRISPR screens combined with bioinformatic analysis can identify genes whose loss or gain alters collagen biosynthesis, enabling unbiased discovery of regulators within GO:0032967. Integrating screen hits with pathway annotation and expression data helps prioritize candidates for validation.
How CRISPR Can Be Used to Study GO:0032967 positive regulation of collagen biosynthetic process
Knockout
CRISPR knockout of candidate genes such as LTBP3, P4HB or ERN1 allows researchers to test whether they are required for positive regulation of collagen biosynthesis, using collagen mRNA, protein and secretion readouts. Knockout models are also used to validate hits from pooled screens.
Point Mutation
Point-mutation knock-in can be used to model specific amino acid changes in regulators or in collagen itself, testing how individual residues affect collagen production and secretion. This approach helps distinguish catalytic or binding-site requirements from scaffold functions.
Knock-in
Knock-in of reporters, tags or regulatory elements at collagen loci enables real-time monitoring of collagen gene expression and protein trafficking, providing dynamic readouts of positive regulation. Tagged knock-in models are particularly useful for secretion and localization studies.
Overexpression
Overexpression of candidate activators such as TGF-beta1 pathway components or LTBP3 can drive collagen biosynthesis and is used to test sufficiency in fibrosis and keloid models. Overexpression models complement loss-of-function studies to establish causality.
How EDITGENE Supports positive regulation of collagen biosynthetic process Research
Researchers studying positive regulation of collagen biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in collagen production, whether a specific variant alters its function, and how changes in gene dosage affect matrix deposition. EDITGENE provides CRISPR-based cell model services that address these questions with validated, publication-ready reagents.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of collagen biosynthetic process research.
Frequently Asked Questions About positive regulation of collagen biosynthetic process
What is GO:0032967 positive regulation of collagen biosynthetic process?
GO:0032967 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, the main fibrous protein of connective tissue.
What genes are involved in positive regulation of collagen biosynthetic process?
Representative genes include COL1A1, COL1A2, COL3A1 and other collagen family members, together with regulators such as LTBP3, TGFB1, P4HB/PDIA1 and ERN1.
How is collagen biosynthesis positively regulated?
It is regulated at multiple levels, including transcriptional activation by growth factors and metabolic signals, post-transcriptional control of mRNA stability and translation, ER folding by proteostasis factors, and secretory pathway trafficking.
Why is positive regulation of collagen biosynthesis important in fibrosis?
Chronic activation of collagen production leads to excessive matrix deposition and organ stiffening, as seen in lung and liver fibrosis, making this process a therapeutic target.
Does lactate affect collagen expression?
Yes, lactate promotes collagen expression, proliferation and migration through H3K18 lactylation-dependent stimulation of the LTBP3/TGF-beta1 axis in keloid fibroblasts.
What role does the ER play in collagen biosynthesis?
The endoplasmic reticulum is where collagen is modified and folded, and ER proteostasis factors such as P4HB/PDIA1, regulated by the IRE1 stress sensor, control this step and influence liver fibrosis.
Can collagen secretion be inhibited therapeutically?
Yes, dextromethorphan inhibits collagen and collagen-like cargo secretion and ameliorates lung fibrosis in experimental models, showing that the secretion step is druggable.
How do I study positive regulation of collagen biosynthetic process in the lab?
Common approaches include RT-qPCR and western blot for collagen expression, secretion assays for export, imaging for matrix deposition, and CRISPR knockout or overexpression to test causality.
Is collagen biosynthesis involved in cancer?
Yes, collagen family genes are involved in tumor enlargement of gastric cancer, and tumor-stroma interaction signaling regulates polarity in mucinous colorectal adenocarcinoma.
What CRISPR models are available for collagen biosynthesis research?
Knockout, point-mutation, knock-in, tagged knock-in and overexpression cell models can be generated to test gene function and dosage effects on collagen production.
Conclusion
GO:0032967, positive regulation of collagen biosynthetic process, captures the diverse signals that increase collagen production, from transcriptional activation by TGF-beta and metabolic cues to ER folding and secretory trafficking. Its dysregulation is central to fibrosis, keloid scarring and tumor stroma biology, making it a high-value area for mechanistic and translational research. CRISPR-based cell models provide a rigorous way to establish causality for candidate regulators and to accelerate the discovery of new intervention points.
References
- 1. Shin SM et al.. 2023. Polydeoxyribonucleotide exerts opposing effects on ERK activity in human skin keratinocytes and fibroblasts.. Mol Med Rep 28(2) PMID: 37350391
- 2. Khan MM et al.. 2024. Dextromethorphan inhibits collagen and collagen-like cargo secretion to ameliorate lung fibrosis.. Sci Transl Med 16(778):eadj3087 PMID: 39693409
- 3. Hazari Y et al.. 2026. Targeting the ER stress sensor IRE1 protects the liver from fibrosis through the downregulation of the proteostasis factor P4HB/PDIA1.. Hepatology 83(1):75-93 PMID: 40202514
- 4. Gu JJ et al.. 2026. Lactate Promotes Collagen Expression, Proliferation, and Migration through H3K18 Lactylation-Dependent Stimulation of LTBP3/TGF-β1 Axis in Keloid Fibroblasts.. J Invest Dermatol 146(2):522-534.e8 PMID: 40633755
- 5. Adams SL. 1989. Collagen gene expression.. Am J Respir Cell Mol Biol 1(3):161-8 PMID: 2696511
- 6. Sun H et al.. 2023. The involvement of collagen family genes in tumor enlargement of gastric cancer.. Sci Rep 13(1):100 PMID: 36596829
- 7. Pasquier N et al.. 2026. Signaling downstream of tumor-stroma interaction regulates mucinous colorectal adenocarcinoma apicobasal polarity.. Nat Commun 17(1) PMID: 42401587
- 8. Raghow R et al.. 1989. Molecular mechanisms of collagen gene expression.. Mol Cell Biochem 86(1):5-18 PMID: 2666848
